Gene · 2271
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
181 to 200 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic and clinical characterization of a novel FH founder mutation in families with hereditary leiomyomatosis and renal cell cancer syndrome. | Orphanet J Rare Dis | 2024 | 38279137 | PubTator, text mining | PubMed |
| Methanobrevibacter massiliense and Pyramidobacter piscolens Co-Culture Illustrates Transkingdom Symbiosis. | Microorganisms | 2024 | 38276200 | PubTator, text mining | PubMed |
| Targeting the Metabolic Paradigms in Cancer and Diabetes. | Biomedicines | 2024 | 38255314 | PubTator, text mining | PubMed |
| Corrigendum to "Post-translational regulation of metabolism in fumarate hydratase deficient cancer cells" [Metabol. Eng. 45 (2018) 149-157]. | Metab Eng | 2024 | 38245482 | PubTator, text mining | PubMed |
| LINC00571 drives tricarboxylic acid cycle metabolism in triple-negative breast cancer through HNRNPK/ILF2/IDH2 axis. | J Exp Clin Cancer Res | 2024 | 38238853 | PubTator, text mining | PubMed |
| Exploring the multifaceted role of NRF2 in brain physiology and cancer: A comprehensive review. | Neurooncol Adv | 2024 | 38221979 | PubTator, text mining | PubMed |
| Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies. | Cell Commun Signal | 2024 | 38216942 | PubTator, text mining | PubMed |
| Remodeling of the human skeletal muscle proteome found after long-term endurance training but not after strength training. | iScience | 2024 | 38213622 | PubTator, text mining | PubMed |
| Ovarian cancer cells regulate their mitochondrial content and high mitochondrial content is associated with a poor prognosis. | BMC Cancer | 2024 | 38191325 | PubTator, text mining | PubMed |
Pathological Complete Response to Pembrolizumab plus Axitinib Combination following Serious Immune-Related Adverse Events in an Advanced Renal Cell Carcinoma Patient with a History of Rheumatoid Arthritis. | Case Rep Oncol | 2024 | 38188482 | PubTator, text mining | PubMed |
| Biochemical characterization on muscle tissue of a novel biallelic ACO2 mutation in an infant with progressive encephalopathy. | JIMD Rep | 2024 | 38186851 | PubTator, text mining | PubMed |
| p32 regulates glycometabolism and TCA cycle to inhibit ccRCC progression via copper-induced DLAT lipoylation oligomerization. | Int J Biol Sci | 2024 | 38169635 | PubTator, text mining | PubMed |
| Improving susceptibility of neuroendocrine tumors to radionuclide therapies: personalized approaches towards complementary treatments. | Theranostics | 2024 | 38164150 | PubTator, text mining | PubMed |
| Update on Selected High-grade Renal Cell Carcinomas of the Kidney: FH-deficient, ALK-rearranged, and Medullary Carcinomas. | Adv Anat Pathol | 2024 | 38145398 | PubTator, text mining | PubMed |
| Malignant glomus tumor arising in association with a fumarate hydratase-deficient leiomyoma: An unusual collision tumor. | J Cutan Pathol | 2024 | 38140939 | PubTator, text mining | PubMed |
| An effective visible-light driven fumarate production from gaseous CO2 and pyruvate by the cationic zinc porphyrin-based photocatalytic system with dual biocatalysts. | Dalton Trans | 2024 | 38032087 | PubTator, text mining | PubMed |
| Fumarate hydratase as a metabolic regulator of immunity. | Trends Cell Biol | 2024 | 37940417 | PubTator, text mining | PubMed |
| Thrombin induces ferroptosis in triple-negative breast cancer through the cPLA2α/ACSL4 signaling pathway. | Transl Oncol | 2024 | 37939630 | PubTator, text mining | PubMed |
| Latest assessment methods for mitochondrial homeostasis in cognitive diseases. | Neural Regen Res | 2024 | 37843209 | PubTator, text mining | PubMed |
| Long noncoding RNAs as versatile molecular regulators of cellular stress response and homeostasis. | Hum Genet | 2024 | 37782337 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2271/papers?page=10